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Abstract 
Caspases play important roles in cell death, differentiation and proliferation. Due to their high 
homology, especially of the active site, specific targeting of a particular caspase using 
substrate analogues is very difficult. Although commercially available small molecules based 
on peptides are lacking high specificity due to overlapping cleavage motives between 
different caspases, they are often used as specific tools. We have selected designed ankyrin 
repeat proteins (DARPins) against human caspases-1 to -9 and identified high-affinity binders 
for the targeted caspases, except for caspase-4. Besides previously reported caspase-specific 
DARPins (Flütsch et al., 2014; Schroeder et al., 2013; Schweizer et al., 2007), we generated 
novel DARPins (D1.73, D5.15, D6.11, D8.1, D8.4 and D9.2) and confirmed specificity for 
caspase-1, -5, -6, and -8 using a subset of caspase family members. In addition, we solved the 
crystal structure of caspase-8 in complex with DARPin D8.4. This binder interacts with non-
conserved residues on the large subunit thereby explaining its specificity. Structural analysis 
of this and other previously published crystal structures of caspase-DARPin complexes 
depicts two general binding areas either involving active site forming loops or a surface area 
laterally at the large subunit of the enzyme. Both surface areas involve non-conserved surface 
residues of caspases. 
Keywords: apoptosis, cell death, specific caspase targeting, DARPins, X-ray 
crystallography. 
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Introduction 
A well-ordered removal of aberrant cells is important in multicellular animals to ensure the 
organism’s cellular integrity. Thus, a variety of cell death pathways exist of which apoptosis 
is presumably one of the best-studied mechanisms, removing cells in non-inflammatory 
manner thereby preventing a severe immune response in the organism (Taylor et al., 2008). 
Further, apoptosis plays a crucial role in embryonic development and tissue homeostasis. 
Although it is a highly controlled mechanism, its misregulation has been associated with 
severe diseases such as cancer or Alzheimer (Favaloro et al., 2012; Rohn, 2010). 
Proteases of the caspase family have been identified to be the major contributors of apoptosis. 
Caspases either induce (caspase-2, -8, -9 and -10) or execute (caspase–3, –6 and –7) the 
apoptotic signaling (Grutter, 2000). Furthermore, caspase–1, –4, –5 and –12 have been related 
to inflammatory pathways. Since all caspases share a high sequence and structural homology, 
specific targeting of one particular family member is limited with the contemporary available 
tools. The small peptide substrates or inhibitors lack specificity due to targeting of the highly 
conserved active site (McStay et al., 2008). Another more promising approach is the 
development of small molecule compounds that bind and inhibit caspase-3 and -7 outside the 
active site pocket, although the identified binding site for these compounds is conserved 
between both caspases (Hardy et al., 2004). 
To increase a compound’s specificity for a particular caspase, we used engineered binding 
proteins that provide larger binding interfaces involving also less-conserved residues. For our 
studies we selected binders using a designed ankyrin repeat protein (DARPin) library. 
DARPins were designed based on repeat modules occurring in natural ankyrin proteins and 
they consist of a N-terminal capping repeat (N-cap) followed by two (=N2C) or three (=N3C) 
internal and a C–terminal repeat (C-cap) (Binz et al., 2004). Each internal repeat of a DARPin 
harbors six randomized positions resulting in a theoretical diversity of 1023 different 
molecules in assembled DARPin libraries (Binz et al., 2004). These libraries are generally 
used for binder selections against various different targets using ribosome display, an in vitro 
selection technique (Hanes & Plückthun, 1997). In addition, DARPins have also been 
successfully selected using phage display (Steiner et al., 2008). 
Numerous DARPin selections yielding high affinity binders for particular target proteins have 
been reported (Amstutz et al., 2005; Sennhauser et al., 2007; Stefan et al., 2011). In the past, 
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we used DARPin libraries to select highly specific inhibitors for caspase-2 (Schweizer et al., 
2007) and caspase-3 (Schroeder et al., 2013) as well as for pro- and active caspase-7 binders 
that prevent procaspase-7 activation (Flütsch et al., 2014). 
Here, we describe the general procedure for the selection of DARPin binders in parallel 
against the panel of human caspase-1 to –9. The selection led to high-affinity binders with the 
exception of caspase-4. Besides the previously reported specific DARPins for caspase–2 
(Schweizer et al., 2007), caspase–3 (Schroeder et al., 2013) and caspase–7 (Flütsch et al., 
2014), we report novel binders for caspase-1, -5, -6, -8 and -9. The binder’s target specificity 
for caspase-1, -5, -6 and -8 was evaluated using a subset of caspase family members. In 
addition, we solved the first crystal structure of caspase-8 in complex with DARPin D8.4 and 
provide a comparison and analysis of the binding interface with the other three previously 
published caspase-2, -3 and -7/DARPin complex interfaces. 
Results 
Caspase purification  
Since the targeted protein’s purity and stability is crucial to prevent selection against 
impurities or degradation products, we have established purification protocols with high 
reproducibility for caspase-1 to -9 (Roschitzki-Voser et al., 2012). The kinetic 
characterization in combination with analysis of the oligomeric state on determined by size 
exclusion chromatography (SEC) and the purity on SDS page ensured that the targeted 
caspases were properly folded and active enzymes. 
Selection and characterization of caspase-targeted DARPins 
DARPin selection was performed using ribosome display against caspases–1 to –9. We 
modified the selection protocol to achieve specificity and introduced pre-panning steps 
against the closest homologues of the targeted caspases in the first and third selection round 
(Supplementary Figure 1). Furthermore, additional washing has been performed to obtain a 
slow off rate using an excess of non-biotinylated targeted caspase after the panning step in the 
second and fourth round (Supplementary Figure 1). After four rounds of selection, the 
enriched caspase-targeted DARPin libraries have been used to analyze individual clones by 
crude extract ELISA. In general, binders that exhibited strong signal to the targeted caspases 
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compared to the maltose-binding protein (MBP) control obtained a unique identifier (DX.Y) 
with X indicating the targeted caspases and Y the sequence of discovery. Obtained DARPins 
were sequenced (Supplementary Figure 2), purified and analyzed for complex formation with 
the targeted caspase in solution using SEC (Figure 1a and Supplementary Figure 3). Notably, 
binding of the DARPins can occur to the monomeric as well as to the dimeric form of the 
targeted caspase. In addition, SEC traces suggest that binding of D1.73 and D8.4 may alter 
the oligomeric state of the targeted caspase. While first results using ultracentrifugation and 
D8.4 support these findings (data not shown), further experiments will be necessary to fully 
confirm an induced change of the oligomeric state upon DARPin binding.  
Affinity of binders that displayed unambiguous sequencing results and a stable complex on 
SEC were analyzed using surface plasmon resonance (SPR) (e.g. Caspase-8/D8.4 in Figure 
1b). Following this approach, we were able to identify DARPins with affinities in the low 
nanomolar range to caspases–1 to –9 with the exception of caspase-4. Measured SPR data for 
these binders are summarized in Figure 1c where we included the previously reported values 
of DARPins with high specificity for caspase-2 (Schweizer et al., 2007), caspase-3 (Schroeder 
et al., 2013) and pro- and activate caspase-7 (Flütsch et al., 2014). Kinetic data have been 
obtained by fitting the measured data with the heterogeneous ligand model (Bravman et al., 
2006) with exception of D9.2 that exhibited a very low signal. Different values of Kd1 and Kd2 
can be explained by altered accessibility of the two binding epitopes most probably 
originating from the direct coating of the caspase molecules via biotin on the sensor chip. 
However, we cannot fully exclude a cooperative binding mechanism in case of the caspase-3 
binders that exhibit a large difference between these two values.  
In case of D8.4, the Langmuir model was used to fit the data (Figure 1b) obtaining a Kd of 
5.2 nM. With the exception of D1.73, D8.1 and D8.4, which exhibited high χ2 values while 
curve fitting, binding constants were determined by equilibrium analysis. DARPins that were 
selected against caspase-4 exhibited binding in the low mM range, three orders of magnitude 
higher than the best binders we have found against the other caspases. An explanation for that 
observation could be that caspase-4 is less stable under selection conditions. Protein sequence 
and biophysical properties of the DARPins listed in Figure 1c can be found in Supplementary 
Table 1. 
Caspase specificity of the selected DARPins was determined using SPR analysis against a 
representative set of caspases (caspase-1, -4, -5, -6, -7 and -8) including members of all 
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different pre-panning groups (see Supplementary Figure 1). Caspase-3 was excluded due to its 
lower stability when coated on the SPR chip whereas caspase-2 and -9 were represented by 
the panning group member caspase–8. Although not all caspases were tested in particular, the 
chosen array of different caspases is well suitable to elucidate the binder’s specificity. It 
confirms that pre-panning during selection leads to not only specificity within a  
panning-group (e.g. caspase-1, -4 and -5) but also across panning groups with more distantly 
related caspases (e.g. caspase-1, -7, -8).  
With the exception of D9.2, we tested and confirmed the binders’ specificity for the targeted 
caspases. Caspase-8 binding specificity was tested using DARPin D8.1, which shares a very 
similar sequence with D8.4 with only two point mutations (Q26R and V139A, see 
Supplementary Figure 5) suggesting the same binding interaction. Binding specificities for 
AR_F2, D3.4S76R, D3.8, D7.18 and D7.43 were reported previously (Flütsch et al., 2014; 
Schroeder et al., 2013; Schweizer et al., 2007). 
Crystal structure of caspase-8 in complex with D8.4 
To obtain a better understanding of the binding interactions between a selected DARPin and 
the targeted caspase, we have crystallized caspase-8 in complex with DARPin D8.4 and 
determined the structure at 1.8 Å resolution. Structure determination details and refinement 
statistics can be found in Supplementary Table 2. Crystals grew under acidic conditions at pH 
4.9 indicating that the protein interaction remains intact even at low pH. This was also tested 
in ELISA format (data not shown) and showed that binding still occurs at acidic pH values, 
although a lower signal compared to neutral pH suggests a weakened binding affinity. The 
asymmetric unit contains a caspase-8 dimer consisting of two small and two large subunits, 
two bound inhibitor molecules Ac-IETD-CHO and two bound DARPins. The binding epitope 
is localized on the side of the large subunit of the enzyme and primarily involves residues of 
α-helix α2 as well as β–strand β2 (Figure 2a).  
In total, 25 caspase-8 residues are involved in binding to 31 residues of the DARPin spanning 
a binding interface of 938 Å2. 16 hydrogen bonds and 7 salt bridges surround a hydrophobic 
core, which is formed by amino acids Phe-56, Leu-86, Leu-89, Phe-90 and Phe-123 of the 
DARPin and Gln–291, Ile–295 and Ile-298 of caspase–8 (Figure 2b). Remarkably, besides the 
16 non-randomized residues that are involved in binding, D8.4 possesses two unintended 
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framework mutations (Arg-26 und Arg-85, see Supplementary Figure 5), which play a role in 
hydrogen bonding to caspase-8 (marked in Figure 2b, left panel). 
As intended, the specificity of D8.4 for caspase-8 is achieved by targeting of non–conserved 
residues. Especially the hydrophobic interaction provided by Ile-298 (Figure 2b, right panel) 
is not conserved among the apoptotic caspases, which harbor a larger and more hydrophilic 
residue at this position (Supplementary Figure 5). Besides that, only Thr-288 at the beginning 
of α–helix α1 was identified as highly conserved. Therefore, our crystal structure not only 
provides insights into the binding interface but also elucidates the specificity of the selected 
DARPin. In addition, it confirms our chosen selection procedure with the additional  
pre-panning steps against homologues caspases. A structural alignment of our  
Caspase-8/DARPin-8.4 structure with the high resolution structure of the same enzyme 
(1QTN; Watt et al., 1999) results in a very low root mean square deviation of about 0.7 Å 
indicating no or only minor differences between the two structures. While they show no 
structural differences in the overall fold and the active site, several side chains in the 
Caspase/DARPin interface adopt different conformations (e.g. Glu-290, Glu-294, Ile-298) due 
to the presence of the binder DARPin-8.4. 
DARPin binding interfaces on human caspases 
With the previously described crystal structures of caspases in complex with specific 
DARPins (Flütsch et al., 2014; Schroeder et al., 2013; Schweizer et al., 2007), we were able 
to compare the different DARPin epitopes for each particular caspase (Figure 3). 
Based on the caspase standard view, where the five main parallel β-strands (β1 - β5) of a 
caspase protomer are aligned with their C-termini pointing upwards, caspase-2 specific 
DARPin AR_F8 (Figure 3a; Schweizer et al., 2007) binds apical at the backside of loop–4 
(also known as loop–381; Fuentes-Prior & Salvesen, 2004), which is involved in the 
formation of the active site cleft. Since this loop is not highly conserved among other 
caspases, it explains the high specificity of DARPin AR_F8 for caspase-2. The binding area 
of 799 Å2 includes a hydrophobic core, 6 hydrogen bonds and 9 salt bridges. AR_F8 binding 
at the backside of loop–4 leads to a loop–shift of 1 Å and opens the active site cleft 
(Schweizer et al., 2007). This finally results in a displacement of the active site cysteine  
(Cys-155) and structurally elucidates the allosteric mode of inhibition. 
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Although DARPin D3.4S76R binds in a similar way apical to caspase–3 (Figure 3b; 
Schroeder et al., 2013) at the active site forming loops, the epitope is only partially 
overlapping with that of caspase–2 and AR_F8. D3.4S76R binds directly into the active site 
pocket of caspase-3 and only interacts with the tip of loop–4. Its high specificity is achieved 
by the formation of a salt-bridge between Lys-56 and the Asp-253 of caspase-3. Interestingly, 
the interacting DARPin residue Asp-45 occupies the S4 pocket of the enzyme as it can be 
observed in binding of peptide substrates. In addition, Ile-78 of the DARPin keeps Tyr-204 of 
caspase-3 in a conformation that blocks the S2 binding pocket. Overall, the binding of 
D3.4S76R to caspase-3 prevents substrate entrance to the active site pocket and mimics an 
interaction seen for caspase–3 with its natural inhibitor XIAP (Schroeder et al., 2013). 
Enzyme kinetic analysis has classified D3.4S76R as a purely competitive inhibitor. 
Besides the apical binding-sites of AR_F8 and D3.4S76R, another favored caspase-DARPin 
epitope could be identified laterally at the large subunit of the peptidase. In addition to the 
above described DARPin D8.4 that binds sideways at the large subunit (p20) primarily to 
residues of α-helix α2 (Figure 3d), DARPins that have been selected against caspase-7 bind at 
a similar epitope (Flütsch et al., 2014). For instance, the crystal structure of caspase–7 in 
complex with DARPin D7.18 (Figure 3c) unraveled a binding interface of 672 Å2 that is 
predominantly formed by residues located on β-strand β2. In particular, two DARPin 
tryptophans (Trp-46 and Trp–78) are deeply buried in a hydrophobic pocket shaped by  
non-conserved residues of caspase-7. Since this hydrophobic pocket is obstructed in other 
homologues, these two tryptophans are the major contributors for the high specificity of 
DARPin D7.18. Although there is another caspase-7/DARPin complex structure available 
(pdb: 4JB8) (Seeger et al., 2013) with DARPin C7_16 binding laterally at the large subunit of 
caspase–7, we excluded this protein complex in our structural analysis. This DARPin has 
been selected without additional pre-panning steps and thus may lack specificity.  
More interestingly, D7.43 and D7.18 also bind to procaspase-7 thus preventing a successful 
activation (Flütsch et al., 2014). D8.4 with a lateral but different binding epitope would 
suggest a potential effect on the activation mechanism in analogy to the caspase-7 DARPins. 
However, the activation mechanism of caspase-8 is different compared to the  
caspase-mediated cleavage of pro-caspase-7. It occurs via autocatalytic processing after 
proximity-induced oligomerization (Salvesen & Dixit, 1999) and therefore is dependent on 
the oligomeric state of caspase-8. Complex-formation on SEC (Figure 1a) and first 
ultracentrifugation experiments (data not shown) demonstrate that D8.4 can bind to the 
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monomer as well as the dimer of caspase-8 in vitro. Whether binding in a cellular 
environment to the full pro-caspase-8 with its two N-terminal death effector domains (DED) 
occurs and modulates caspase-8 activation has not been further analyzed and remains 
unknown. 
All the complex structures display binding of one selected DARPin to one caspase protomer 
thus every caspase dimer has two DARPins bound. A superposition of all DARPins on 
caspase-8 shows the particular difference between the binding interfaces and emphasizes 
similarities (Figure 3e). While the apical epitope of DARPin AR_F8 is located at the backside 
of loop-4, D3.4S76R binds inside the active site cleft and completely blocks an entrance of 
substrate. The lateral binding at the large subunit is less distinct. The C-cap of DARPin D7.18 
and D8.4 share a similar binding area on the caspase surface but their position is slightly tilted 
by an angle of 30° towards the N-cap. Notably, the N-terminus of all DARPins is oriented to 
the backside in the standard caspase representation resulting in a “dorsal to ventral” DARPin 
orientation.  
Comparison of these DARPin epitopes on the caspase surface suggests that binding in 
specific manner is more likely if it occurred at the outer rim of the enzyme rather than 
centrally located close to the dimer interface of two caspase protomers. However, we cannot 
exclude that this finding is experimentally influenced by the immobilization of the caspase 
molecule during the selection procedure. Random chemical biotinylation may orient the 
enzyme in a particular direction that binding to the outer rim is more likely. Besides that, it 
has been shown that the central cavity formed by two caspase protomers is conserved between 
caspase-3 and -7 (Hardy et al., 2004), suggesting a less favoured epitope for high  
caspase-specificity in close proximity to the cavity. In addition, exosite studies on caspase-7 
revealed that surface residues located at the large subunit influence the cleavage efficiency for 
particular substrates (Boucher et al., 2012). For example, a caspase-7 mutant (K69L) 
exhibited reduced processing of the Hsp90 cochaperone p23. More interestingly, Lys-69 is 
also involved in binding to DARPin D7.18, is not conserved in other caspases  
(see Supplementary Figure 6) and the caspase-8 homologue residue (Tyr-235) also contributes 
to DARPin D8.4 binding. Although very preliminary, this finding indicates that the  
non-conserved caspase residues involved in DARPin binding might also be of importance in 
providing specific binding interactions to certain caspase substrates. 
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Discussion 
Using the here described DARPin selection procedure including pre-panning steps against 
close homologs, we obtained new binders against five members of the human caspase family. 
We characterized these novel DARPins for caspases-1, -5, -6, -8 and -9 and included data of 
the previously reported specific binders for caspases-2, -3 and -7 (Flütsch et al., 2014; 
Schroeder et al., 2013; Schweizer et al., 2007). Caspase-specificity of the new DARPins 
D1.73, D5.15, D.6.11 and D8.1 was tested using a subset of caspase family members 
(caspase-1, -4, -5, -6, -7, -8). Although our results suggest high target specificity, binding of 
the DARPins to caspase-2, -3 and -9 was not tested. 
The crystal structure of caspase-8 in complex with DARPin D8.4 provides insights into the 
binding mode of this high affine binder. D8.4 binds lateral to the large p20 subunit of the 
enzyme and does not interfere with the active site of the enzyme. The binding interface of 
caspase-8 involves a hydrophobic patch consisting of several non-conserved caspase residues 
and thus explains its specificity. Although the previously reported DARPins for caspases-2, -3 
and -7 are binders with inhibitory function (Flütsch et al., 2014; Schroeder et al., 2013; 
Schweizer et al., 2007), the here newly reported DARPins do not prevent cleavage of small 
peptide substrates in vitro. If these binders can interact with the targeted procaspases and 
interfere with the activation process has not been tested and needs to be addressed in future 
experiments.  
A structural comparison of all available caspase-DARPin complexes reveals two distinct 
binding regions on caspases for the selected DARPins. One is located apical close or at the 
active site. Here the DARPins interact with active site forming loops or with residues in the 
active site and thereby inhibit the enzyme either allosterically or competitively. The other 
favored region is found laterally at the large subunit of the peptidase and involves α-helix α1 
and α2 as well as β-strand β2. With this study we show that specific DARPins can be selected 
against a particular member of a highly homologous protein family sharing a high sequence 
identity. Thus, these DARPins provide a molecular toolbox for functional and structural 
investigations either in vitro or in cell based assays using mammalian expression vectors.  
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Materials and methods 
All reagents were bought from Sigma/Fluka if not stated otherwise. Sequencing was 
performed at Microsynth (Balgach, Switzerland).  
Caspase purification and biotinylation 
Caspase–1 to –9 have been purified as described previously (Roschitzki-Voser et al., 2012). 
Ribosome display selection and ELISA experiments were performed using chemically 
biotinylated caspases [EZ-Link Sulfo-NHS-LC-LC-Biotin (21338, Pierce)]. After 
purification, 1 ml of caspase (10 µM) in PBS pH 7.3 or 50 mM HEPES pH 7.5 containing 
150 mM NaCl was incubated with a molar excess (7x, 70 µM) of biotin on ice for 30 min. 
The reaction was quenched by adding 5 M Tris pH 7.5 (10 µl). Biotinylated proteins were 
purified by SEC using a Superdex 200 10/300 GL (GE Healthcare) equilibrated in phosphate 
buffer saline (PBS) at 4°C. Fractions containing biotinylated caspases were pooled, frozen in 
liquid nitrogen after adding sucrose (10%) and stored at –80°C in small aliquots. 
DARPin selection by ribosome display 
Cloning and amplification of a DARPin library has been described previously (Binz et al., 
2003) and a library containing N3C and N2C DARPins was used for selections by ribosome 
display (Hanes & Plückthun, 1997; Zahnd et al., 2007). The selection procedure was slightly 
modified with focus on specificity and low koff rates (see Supplementary Figure 1). To prevent 
unspecific binding to random proteins, each round included a pre-panning step for MBP 
(coated 22 nM). In addition, two of the most homologues caspases were included in pre-
panning steps (coated 22 nM) in round n°1 and n°3. koff maturation was done by adding a  
100- and 500-fold excess of unbiotinylated caspase for 5 or 10 min in round n°2 and n°4, 
respectively. Unbound DARPin-ribosome complexes were washed after each round with 
increasing stringency (Supplementary Figure 1). The enriched library was cloned after 
4 selection rounds into a pQE30 vector and transfected to XL1-Blue E.coli cells (Stratagene). 
Crude extract ELISA 
Single E.coli colonies, each expressing one selected DARPins, were picked and inoculated in 
900 µl auto-inducing media (Studier, 2005) using 96-well plates (Abgene, UK). Cells grew 
over night at 37°C. 200 µl of each well were then transferred to a 96 well plate (Nunc) for 
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plasmid preparation and 700 µl were harvested by centrifugation. Cells were lysed using  
B-PER II (50 µl, 78260, Pierce) per well (30 min, shaking at room temperature). Lysis buffer 
was neutralized with PBS (950 µl) and cell debris was removed by centrifugation (20 min, 
4500 rpm at 4°C). 20 µl supernatant were transferred to 384 well ELISA plates (Nunc), which 
were prepared in advance with either immobilized MBP or targeted caspase. For 
immobilization, plates were coated using neutravidin solution (20 µl à 22 nM, Pierce, 31000), 
followed by incubation of biotinylated proteins and extensive washing. Cell lysate 
supernatants containing the expressed DARPin were incubated for 1 h at room temperature. 
After 3 washing cycles (PBS), each well was incubated with mouse anti-RGS-H4 antibody 
(34650, Qiagen, 1:2000 in PBS + 1% BSA). After washing, the secondary antibody  
(goat-α-mouse IgG alkaline phosphatase conjugate from Sigma, A3562) was incubated. After 
4 washing cycles, the substrate (3 mM di-sodium 4-nitrophenyl phosphate (pNPP) in 50 mM 
NaHCO3, 50 mM MgCl2) was added and OD405nm was measured using a multi-well plate 
reader (Tecan Infinity M1000, Austria). DARPins exhibited strong signals (> 5-fold vs. MBP 
control) were sequenced. 
Expression and purification of DARPins 
DARPins were expressed in auto-inducing media (Studier, 2005) over night or in 2YT  
(3 h at 37°C) after the induction with isopropyl β-D-1-thiogalactopyranoside (0.5 mM, IPTG) 
at an OD600nm between 0.6 - 1. Cells were harvested (6000 rpm, 5 min, 4°C, Biofuge primo R, 
Heraeus) and lysed by ultrasonification. DARPin purification was performed by immobilized 
metal-affinity chromatography [gravity columns, 0.5 ml Ni2+-NTA agarose beads  
(30210, Qiagen)]. DARPins were eluted in PBS, 200 mM imidazole, pH 7.4. Imidazole was 
removed using a PD-10 desalting column (17-0435-01, GE Helthcare). For storage at 4°C, 
0.05% sodium azide (NaN3) was added whereas 20% glycerol was used for storage at -20°C. 
Complex formation on SEC 
Purified caspases were incubated with a two-fold molar excess of selected DARPins. Protein 
solutions were applied on SEC using a Superdex 200 5/150 GL column (GE Healthcare) 
equilibrated in 50 mM Tris, 150 mM NaCl, pH 7.5. Absorption at 280 nm was recorded and 
analyzed in Prism (GraphPad, Version 5). 
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Surface plasmon resonance (SPR) analysis 
SPR experiments were performed using a Proteon XPR36 (Bio-Rad Laboratories, Inc.) and a 
NLC sensor chip. Sterile filtered PBS, pH 7.3, 0.005% Tween-20 was the standard buffer for 
all coating and kinetic measurements. Approximately 1000 RU of biotinylated caspases  
(5 nM) were coated on the chip at 30 µl/min. Dilution series of DARPin analytes were 
prepared prior to the experiment in 96 well plates and sealed to prevent evaporation or 
contamination. At least eight different concentrations (0 to 500 nM) starting with the lowest 
concentration were measured at 20°C. Due to the heterogeneity of the system, the chip surface 
was not regenerated between different analyte concentration but dissociation time could be 
prolonged up to 30 min. In general, experiments were performed at flow rates of 100 µl/min 
with 5 min association phases and 20 min dissociation phases. Recorded data were processed 
and evaluated using ProteOn Manager 2.1.1 (BioRad). Binding kinetics and affinities were 
determined by equilibrium analysis or curve fitting (Bravman et al., 2006). 
Crystallization of caspase-8 in complex with DARPin D8.4 
Caspase-8 was incubated with a two-fold molar excess of DARPin D8.4 (10 min on ice). The 
formed complex was separated using a Superdex 200 10/300 GL column (GE Healthcare) 
20 mM Tris, pH 7.5 (4°C), 20 mM NaCl. Fractions containing the dimeric caspase-8/D8.4 
complex were pooled and concentrated (15 - 21 mg/ml) using an Amicon Ultra centrifugation 
device (Millipore, 10 kDa MWCO). Prior to crystallization, the protein solution was 
incubated with a peptide aldehyde inhibitor Ac-IETD-CHO (two inhibitors per active site). 
Crystals were grown at room temperature using sitting-drop vapor-diffusion method  
(100 mM citric acid, pH 4.9, 200 mM Li2SO4 and 22.4% PEG 4000). For cryoprotection, the 
crystals were equilibrated in reservoir buffer containing ethylene glycol (10-15%) and flash 
frozen in a nitrogen stream at -170°C. 
X-ray diffraction, data collection and structure determination 
Diffraction data were collected at the Swiss Light Source (SLS, X06SA beamline) on a 
Pilatus 6M fast readout pixel detector. XDS (Kabsch, 2010) was used for data processing. The 
crystal structure was solved by molecular replacement using PHASER (McCoy et al., 2007) 
and the structure of caspase–8 (1QDU) (Blanchard et al., 1999) and a N3C–DARPin (2QYJ) 
(Merz et al., 2008) as search model. Structure refinement was performed with REFMAC 
5.5.01.09 (Murshudov et al., 1997) and binding interface analysis was done using the EPPIC 
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server (Duarte et al., 2012) (www.eppic-web.org). Structure figures were prepared in PyMOL 
(http://www.pymol.org). 
Accession numbers 
Atomic coordinates and structure factors of caspase-8/D8.4 were deposited in the Protein Data 
Bank (2Y1L). 
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Figures 
 
Figure 1 Binding characterization of selected DARPins. 
(a) Selected DARPins were analysed on size exclusion chromatography (SEC) for the 
formation of a stable complex in solution (see also Supplementary Figure 3). Caspase-8 
exhibits a monomer-dimer equilibrium (marked with (m) and (d) respectively). D8.4 binds to 
both, the monomer and dimeric form of caspase-8 and elutes at earlier retention volume as a 
protein complex (solid lines, complex peak marked with (C) and (Dp) for DARPin excess). 
Calibration curve (right ordinate) was made using aldolase (158kDa), conalbumin (75 kDa), 
ovalbumin (43 kDa), carbonic anhydrase (29 kDa), ribonuclease A (13.7 kDa) and aprotinin 
(6.5 kDa). Furthermore, (b) binding affinities were determined using surface plasmon 
resonance. (c) Binding affinities and kinetic constants of selected DARPins. Binders with two 
indicated kinetic constants were determined using the heterogeneous ligand model  
(Bravman et al., 2006). D8.1 and D8.4 kinetic data were determined using the Langmuir 
model. The equilibrium KD determination for D1.73, D8.1 and D8.4 resulted in high χ2 values 
and are therefore excluded. Previously reported DARPins are indicated with a gray 
background and references are given with numbers: (1) (Schweizer et al., 2007), (2) 
(Schroeder et al., 2013), (3) (Flütsch et al., 2014). 
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Figure 2 Caspase-8 in complex with DARPin D8.4. 
(a) Standard-view of caspase-8 (small subunit in light gray, large subunit in dark gray,  
Ac-IETD-CHO inhibitor in orange) in complex with DARPin D8.4 (N- and C-cap in dark 
blue, internal repeats are light blue). The DARPin binds lateral at the large subunit of the 
enzyme. (b) Close-up view of the caspase-8/DARPin D8.4 binding interface displaying the 
major interactions between the DARPin and α–helix α2 of caspase-8 (left panel) and 180° 
rotated to show the interactions of D8.4 with β-strand β2 of caspase-8 (right panel). Important 
residues are labeled in blue (DARPin) and gray (caspase-8). See also Supplementary  
Figure 5 for a list of interacting residues. 
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Figure 3 Caspase-specific DARPins: complex structure overview. 
Currently available caspase structures in complex with specific DARPins are shown in 
standard-view and rotated (90° around the y-axes). Interacting residues on the caspase surface 
are colored according to the color of the binding DARPin. (a) AR_F8 binds caspase-2 from 
the backside of loop-4. (b) D3.4S76R blocks the active site cleft of caspase-3. (c) D7.18 binds 
at the large subunit (p20) of caspase-7. (d) A similar epitope can be observed for caspase-8 
specific DARPin D8.4. (e) Superposition of all DARPins on caspase-8 visualizes the different 
epitopes. See also Supplementary Figure 6 for a sequence alignment of all caspases and the 
interacting caspase residues. 
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